 occurr neoplasia patient rheumatoid arthriti dmard registri rheumatoid arthriti azathioprin registri steer committe rheumatoid arthriti azathioprin registri raar safeti azathioprin aza diseas agent dmard treatment RA yearli followup past year malign condit dmard adult patient RA incid densiti ratio idr standard morbid ratio smr cancer risk cancer smr CI men smr CI women smr CI age idr studi popul age sex smr lymphoprolif disord myeloma CI smr lung cancer CI gener popul patient RA dmard therapi increas risk malign lymphoprolif disord raar import prospect techniqu assess neoplasia risk type durat dmard therapi